These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15888164

  • 1. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J, Picard-Dahan C, Marinho E, Grossin M, Yeni P, Leport C, Vildé JL, Crickx B, Descamps V.
    Br J Dermatol; 2005 May; 152(5):1026-9. PubMed ID: 15888164
    [Abstract] [Full Text] [Related]

  • 2. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS.
    Cancer; 2002 Jul 01; 95(1):147-54. PubMed ID: 12115328
    [Abstract] [Full Text] [Related]

  • 3. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
    Fardet L, Stoebner PE, Bachelez H, Descamps V, Kerob D, Meunier L, Dandurand M, Morel P, Lebbe C.
    Cancer; 2006 Apr 15; 106(8):1785-9. PubMed ID: 16534786
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J, Wildfire A, Portsmouth S, Powles T, Thirlwell C, Hewitt P, Nelson M, Patterson S, Mandalia S, Gotch F, Gazzard BG, Bower M.
    Ann Oncol; 2003 Nov 15; 14(11):1660-6. PubMed ID: 14581275
    [Abstract] [Full Text] [Related]

  • 5. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G, Talamini R, Antinori A, Martellotta F, Jacchetti G, Chiodo F, Ballardini G, Stoppini L, Di Perri G, Mena M, Tavio M, Vaccher E, D'Arminio Monforte A, Tirelli U, AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals.
    J Clin Oncol; 2003 Aug 01; 21(15):2876-82. PubMed ID: 12885804
    [Abstract] [Full Text] [Related]

  • 6. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M, Weir J, Francis N, Newsom-Davis T, Powles S, Crook T, Boffito M, Gazzard B, Nelson M.
    AIDS; 2009 Aug 24; 23(13):1701-6. PubMed ID: 19550283
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
    Yoshioka MC, Alchorne MM, Porro AM, Tomimori-Yamashita J.
    Int J Dermatol; 2004 Sep 24; 43(9):643-7. PubMed ID: 15357742
    [Abstract] [Full Text] [Related]

  • 8. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
    Hermans P, Clumeck N, Picard O, van Vooren JP, Duriez P, Zucman D, Bryant JL, Gill P, Lunardi-Iskandar Y, Gallo RC.
    J Hum Virol; 1998 Sep 24; 1(2):82-9. PubMed ID: 10195236
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT.
    J Clin Oncol; 1999 Jun 24; 17(6):1876-83. PubMed ID: 10561228
    [Abstract] [Full Text] [Related]

  • 10. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM.
    Leukemia; 1994 Jun 24; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T, Stebbing J, Bower M.
    Expert Rev Anticancer Ther; 2005 Apr 24; 5(2):215-9. PubMed ID: 15877519
    [Abstract] [Full Text] [Related]

  • 12. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW, Remick SC, Azarnia N, Proper JA, Barrueco JR, Dezube BJ.
    Clin Cancer Res; 1999 Nov 24; 5(11):3432-7. PubMed ID: 10589755
    [Abstract] [Full Text] [Related]

  • 13. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F, de Andrade HF, Fernandes ER, Tuon FF, Brasil RA, Pagliari C, Duarte MI.
    Br J Dermatol; 2008 Sep 24; 159(4):839-46. PubMed ID: 18644020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.
    AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700
    [Abstract] [Full Text] [Related]

  • 16. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM, Calabrò ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, Chieco-Bianchi L.
    J Natl Cancer Inst Monogr; 2001 Jun 19; (28):44-9. PubMed ID: 11158206
    [Abstract] [Full Text] [Related]

  • 17. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Lim ST, Tupule A, Espina BM, Levine AM.
    Cancer; 2005 Jan 15; 103(2):417-21. PubMed ID: 15578686
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.
    Int J Oncol; 2005 Sep 15; 27(3):779-85. PubMed ID: 16077928
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan 15; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 20. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR, Krown SE, Testa MA, Cooley TP, Von Roenn JH.
    J Clin Oncol; 2002 Aug 01; 20(15):3236-41. PubMed ID: 12149296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.